Day Three: Diabetes genetic risk score aids discovery of novel monogenic subtypes
The type 1 diabetes genetic risk score differentiates between patients with monogenic and polygenic autoimmune diabetes and can thus be used to aid the discovery of novel genes associated with the monogenic form.
Day Three: Gigantism: The importance of FIPA, AIP mutations and X-LAG
Recent developments in the field of pituitary gigantism, including the discovery of a new syndrome and genes related to this syndrome, were presented in a plenary session at the 58th Annual ESPE Meeting in Vienna, Austria.
Day Two: New classification system proposed for idiopathic short stature
The genetic causes of short stature are highly heterogenous and a new classification system for these children is needed, delegates were told at the 58th Annual ESPE Meeting in Vienna, Austria.
Day Two: Growth and growth factor research highlights presented at ESPE 2019
Growth hormone therapy in young children with Prader-Willi syndrome, genes linked to isolated short stature, and the role of insulin-like growth factor -2 in autoimmune disease are the subjects of three papers included in the 2019 Yearbook of Paediatric Endocrinology.
Day One: Key management points for young women with Turner syndrome described
Oestrogen is key to the management of adolescents and young women with Turner syndrome, with hormone replacement therapy generally preferable to the contraceptive pill, delegates were told at the 58th Annual ESPE Meeting in Vienna, Austria.
Day One: Sleep quality must be taken seriously
A plenary session at the 58th Annual ESPE Meeting in Vienna, Austria, has highlighted how wide-ranging the risks associated with sleep and circadian rhythm disruption are.
Springer Healthcare IME invites you to register for a live webinar on growth disorders in the APAC region
REGISTER HERE Short stature management and growth hormone therapy in the Asia Pacific region Live broadcast from Seoul, Korea Saturday November 30, 2019, at 11:00 to 12:30 (KST) This webinar [...]
ESPE 2019
During ESPE 2019 in Vienna, medwireNews reported on original research and symposium discussions covering a wide range of topics including the management of Turner syndrome in adolescents and young adults, the dynamics of childhood obesity, e-reporting of rare endocrine conditions, genetic disorders of growth, the importance of sleep, and novel monogenic forms of autoimmune diabetes.
One in five childhood cancer survivors experience growth hormone deficiency
Growth hormone deficiency is common among childhood cancer survivors and is associated with the use of hypothalamic-pituitary radiotherapy, alkylating agents and intrathecal chemotherapy, as well as adverse health outcomes, say researchers.
Research focus: ‘Health not height’ – Trial results for a targeted treatment for children with achondroplasia
Professor Ravi Savarirayan talks through the recently published results in The New England Journal of Medicine for the C-type natriuretic peptide analogue vosiritide in children with achondroplasia.
